- Celgene's long-awaited Crohn's disease data leaves questions $CELG
- PTC hit with setback in attempt to ride Sarepta's coattails $PTCT $SRPT
- Kite Pharma lays out its vision for the future at R&D Day $KITE
- FDA and EMA regulators make waves on rare diseases, transparency $SRPT
- $CRSP IPO completes the "CRISPR trifecta" $EDIT $NTLA
- Puma "leads" latest round of biotech fundraising $PBYI $SNSS $NKTR
- Third time is the charm for Alkermes depression drug $ALKS $CERC
- As seen on the stream (the best of the rest including $ACAD $ALNY $ARIA $CRBP $DEPO $GILD $MDCO $PFE $PRQR $RIGL $SGMO $XBI $IBB
Read on: Biotech Tweets of the Week (October 16-21, 2016)